Before Invest
THERMO FISHER SCIENTIFIC INC. logo

THERMO FISHER SCIENTIFIC INC.

TMO
Measuring And Controlling Devices Nec
Last filing · Quarter 2 · Jun 27, 2026
Financial Statements Ratios
Export XLSX
Statement
Income StatementBalance Sheet
Period
Annual Quarterly
Order
Unlock 39 quarters
Format
% Change
Rows
USD ($)
$ in Millions 		Jun 27, 2026Mar 28, 2026Sep 27, 2025Jun 28, 2025Mar 29, 2025Sep 28, 2024Jun 29, 2024Mar 30, 2024Sep 30, 2023Jul 1, 2023Apr 1, 2023Oct 1, 2022Jul 2, 2022Apr 2, 2022Oct 2, 2021Jul 3, 2021Apr 3, 2021Sep 26, 2020Jun 27, 2020Mar 28, 2020Sep 28, 2019Jun 29, 2019Mar 30, 2019Sep 29, 2018Jun 30, 2018Mar 31, 2018Sep 30, 2017Jul 1, 2017Apr 1, 2017Oct 1, 2016Jul 2, 2016Apr 2, 2016Sep 26, 2015Jun 27, 2015Mar 28, 2015Sep 27, 2014Jun 28, 2014Mar 29, 2014Sep 28, 2013Jun 29, 2013Mar 30, 2013Sep 29, 2012Jun 30, 2012Mar 31, 2012Oct 1, 2011Jul 2, 2011Apr 2, 2011Jul 3, 2010Apr 3, 2010Sep 26, 2009Jun 27, 2009
Current assets:
                                                   
Cash and cash equivalents
$ 4,064
$ 3,254
$ 1,982
$ 4,576
$ 4,134
$ 4,645
$ 7,073
$ 5,499
$ 6,151
$ 3,133
$ 3,482
$ 2,919
Short-term investments
0
2
1,564
1,814
1,813
2,000
1,750
1,751
-
-
-
-
Accounts receivable, less allowances of $148 and $147
9,451
9,204
8,911
8,594
8,455
8,255
7,943
7,931
8,370
8,019
7,922
7,671
Inventories
5,627
5,496
5,745
5,559
5,224
5,430
5,198
5,133
5,404
5,655
5,664
5,722
Contract assets, net
1,688
1,684
1,620
1,441
1,366
1,541
1,487
1,422
1,465
1,467
1,375
1,248
Refundable income taxes
-
-
-
-
-
-
-
-
-
-
-
-
Deferred tax assets
-
-
-
-
-
-
-
-
-
-
-
-
Inventories:
                                                   
Raw materials
-
-
-
-
-
-
-
-
-
-
-
-
Work in process
-
-
-
-
-
-
-
-
-
-
-
-
Finished goods
-
-
-
-
-
-
-
-
-
-
-
-
Other current assets
2,536
2,677
2,472
2,599
2,387
1,911
2,025
1,904
1,702
1,721
1,766
1,739
Total current assets
23,365
22,316
22,295
24,584
23,378
23,783
25,476
23,640
23,092
19,995
20,209
19,299
Property, Plant and Equipment, at Cost
-
-
-
-
-
-
-
-
-
-
-
-
Less: Accumulated depreciation and amortization
-
-
-
-
-
-
-
-
-
-
-
-
Property, plant and equipment, net
10,755
10,658
10,177
9,635
9,331
9,412
9,282
9,324
9,167
9,292
9,354
8,628
Acquisition-related intangible assets, net
18,606
19,146
16,242
15,148
15,323
16,262
15,519
16,048
17,091
17,437
17,972
17,813
Other assets
5,616
5,973
5,019
4,615
4,516
4,180
4,377
4,241
4,124
4,108
3,983
4,308
Goodwill
54,832
55,187
49,287
47,249
46,493
46,726
43,843
43,843
43,583
43,273
43,140
40,488
Total assets
113,174
113,281
103,020
101,230
99,041
100,364
98,496
97,095
97,057
94,105
94,658
90,536
Liabilities, redeemable noncontrolling interest and equity
                                                   
Current liabilities:
                                                   
Short-term obligations and current maturities of long-term obligations
3,368
3,090
3,823
2,214
2,819
4,116
5,121
4,451
4,795
4,814
6,122
1,010
Accounts payable
3,268
3,344
3,120
2,980
3,049
2,606
2,547
2,555
2,508
2,423
2,798
2,471
Accrued payroll and employee benefits
1,694
1,565
1,884
1,518
1,419
1,823
1,495
1,314
1,460
1,310
1,307
1,864
Contract liabilities
2,918
2,928
2,852
2,805
2,866
2,663
2,591
2,632
2,547
2,590
2,662
2,567
Accrued income taxes
-
-
-
-
-
-
-
-
-
-
-
-
Deferred revenue
-
-
-
-
-
-
-
-
-
-
-
-
Other accrued expenses
3,823
3,694
3,209
3,200
3,022
3,393
3,019
2,985
2,848
2,975
2,995
3,206
Total current liabilities
15,069
14,621
14,888
12,718
13,174
14,601
14,772
13,937
14,158
14,112
15,884
11,118
Deferred income taxes
1,579
2,107
842
624
1,041
1,123
1,516
1,811
2,620
2,842
2,976
3,140
Other long-term liabilities
4,538
4,421
4,278
4,270
3,971
4,343
4,391
4,567
4,326
4,042
4,230
4,401
Long-term obligations
39,181
40,071
31,857
33,015
31,370
31,197
30,284
31,157
30,489
29,194
29,135
28,150
Redeemable noncontrolling interest
121
121
129
126
128
127
115
119
118
113
123
119
Equity:
                                                   
Incremental Convertible Debt Obligation
-
-
-
-
-
-
-
-
-
-
-
-
Thermo Fisher Scientific Inc. shareholders’ equity:
                                                   
Preferred stock, $100 par value, 50,000 shares authorized; none issued
0
0
0
0
0
0
0
0
0
0
0
0
Common stock, $1 par value, 1,200,000,000 shares authorized; 445,673,899 and 445,160,301 shares issued
446
445
445
444
444
444
443
443
442
441
441
440
Capital in excess of par value
18,870
18,713
18,330
18,232
18,111
17,831
17,649
17,482
17,165
17,030
16,889
16,596
Retained earnings
62,194
60,632
57,354
55,901
54,447
51,421
49,940
48,542
45,869
44,289
43,064
40,452
Treasury stock at cost, 75,926,613 and 68,938,831 shares
26,370
25,360
22,310
21,269
21,269
18,227
18,187
18,186
15,121
15,084
15,083
11,011
Accumulated other comprehensive income/(loss)
(2,460)
(2,497)
(2,801)
(2,797)
(2,343)
(2,477)
(2,413)
(2,764)
(3,027)
(2,924)
(3,054)
(2,928)
Total Thermo Fisher Scientific Inc. shareholders’ equity
52,679
51,934
51,018
50,512
49,390
48,992
47,432
45,516
45,328
43,752
42,257
43,549
Noncontrolling interests
7
7
7
(35)
(33)
(20)
(12)
(12)
18
50
53
59
Total equity
52,686
51,940
51,024
50,476
49,357
48,972
47,419
45,504
45,346
43,802
42,310
43,608
Total liabilities, redeemable noncontrolling interest and equity
$ 113,174
$ 113,281
$ 103,020
$ 101,230
$ 99,041
$ 100,364
$ 98,496
$ 97,095
$ 97,057
$ 94,105
$ 94,658
$ 90,536